Companies
XtalPi
XtalPi Science platform coupling Genius Agents (AI planning) with a physical autonomous lab for closed-loop drug-discovery validation, HKEX:2228.
- Country
- China
- Ticker
- HKEX:2228
Commercial
HKEX:2228
XtalPi Science autonomous lab
Coverage
| CN | EU | US | |
|---|---|---|---|
| automation-robotics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | RMB2,536.8 million raised through convertible bonds in 2026 (2026-01-01) | ir.xtalpi.com · hkexnews.hk |
| Revenue | RMB393.6 million for the first half of 2026 (2026-06-30) | hkbusinesswire.com · prnewswire.com · www1.hkexnews.hk |
| Headcount | Over 1,000 employees (2026-09-02) | en.xtalpi.com |
| Production site | Shenzhen, China; Shanghai, China; Boston, MA, USA (2026-09-02) | en.xtalpi.com |
| Certification | Self GRAS certification for Tensotide in the U.S. (2026-05-31) | hkexnews.hk |
Independent sources: hkbusinesswire.com · hkexnews.hk · prnewswire.com · www1.hkexnews.hk
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cloud laboratories | automation-robotics | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.